&. Matériel and .. , 21 2.1. Les recommandations, 21 2.2. Analyse bibliométrique des références des recommandations concernant l'hypertension, p.25

. Eriksson-95 and T. Dutch, Les méta-analyses et revues systématiques, p.45

.. La-pression-artérielle-en-prévention-primaire, Seuil définissant l'hypertension et seuil d, intervention

.. En-pratique, 1. Comment prendre la tension?

H. Autorité and D. Santé, Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study, 2008.

M. J. O-'donnell, D. Xavier, and L. Liu, Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study, The Lancet, vol.376, issue.9735, pp.112-135, 2010.
DOI : 10.1016/S0140-6736(10)60834-3

P. Rashid, J. Leonardi-bee, and P. Bath, Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events: A Systematic Review, Stroke, vol.34, issue.11, pp.2741-2748, 2003.
DOI : 10.1161/01.STR.0000092488.40085.15

H. Autorité-de-santé, S. Kaplan, N. Mendis, and . Poulter, International Society of Hypertension (ISH) statement on management of hypertension World Health Organization Detection, Evaluation, and Treatment of High Blood Pressure Guidelines for management of hypertension : report of the fourth working party of the British Hypertension Society, World Health Organization International Society of Hypertension Writing Group N Journal of hypertension A. Hypertension Journal of the American Medical Association Journal of Human Hypertension, vol.6, issue.18, pp.1983-1992, 2003.

L. R. American-guidelines-on-hypertension, M. Sanchez, H. Ayala, and . Baglivo, Reappraisal of European guidelines on hypertension management : a European Society of Hypertension Task Force document, Journal of Hypertension Journal of Hypertension, vol.27, issue.27, pp.905-922, 2009.

R. R. Quinn, B. R. Hemmelgarn, and R. S. , The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I ??? blood pressure measurement, diagnosis and assessment of risk, The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 ? therapy, pp.241-248, 2010.
DOI : 10.1016/S0828-282X(10)70378-0

D. G. Hackam, N. A. Khan, and B. R. Hemmelgarn, The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 ??? therapy, Canadian Journal of Cardiology, vol.26, issue.5, pp.249-258, 2010.
DOI : 10.1016/S0828-282X(10)70379-2

D. Wade, A. Rudd, and M. Brown, National clinical guideline for stroke Scottish Intercollegiate Guidelines Network Management of Patients with Stroke or TIA: assessment, investigation, immediate management and secondary prevention, London: Royal College of Physicians, 2008.

K. Brown, T. Howe, and R. Madhok, Guidelines for Management of ischaemic Stroke and Transient Ischaemic Attack, 2008.

P. A. Ringleb, M. Bousser, and G. Ford, Clinical Guidelines for Stroke Management, The European Stroke Organization (ESO) Executive Committee ans the ESO Writing Committee Canadian Best Practice Recommendations for Stroke Care, pp.457-507, 2008.

M. P. Lindsay, G. Gubitz, and M. Bayley, Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial, Stroke Lancet, vol.20, issue.351, pp.227-276, 1998.

L. E. Lewis, W. R. Hunsicker, and . Clarke, Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes, New England Journal of Medicine, vol.345, issue.12, pp.851-886, 2001.
DOI : 10.1056/NEJMoa011303

J. L. Probstfield, E. Schron, and J. A. Cutler, Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study, American Medical Association Lancet British Medical Journal New England Journal of Medicine PROGRESS Collaborative Group. S. MacMahon, B. Neal, C. Tzourio et al. LancetLIFE Lancet, vol.265, issue.359, pp.3255-3264, 1991.

R. Lewington, N. Clarke, and . Qizilbash, Age-specific relevance of usual blood pressure to vascular mortality, The Lancet, vol.361, issue.9366, pp.1903-1913, 2002.
DOI : 10.1016/S0140-6736(03)13064-4

C. D. Furberg, J. T. Wright, and B. R. Davis, Components of blood pressure and risk of atherothrombotic brain infarction: the Framingham study Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias S, Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context, pp.2981-2997, 1976.

R. Collins, R. Peto, and S. Macmahon, Blood pressure, antihypertensive drug treatment and the risks of stroke and coronary heart disease Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, Use of ramipril in preventing stroke: double blind randomised trial, pp.827-838, 1990.

J. Bosch, S. Yusuf, and J. Pogue, Blood Pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature, British Medical Journal Hypertension Research, vol.324, issue.32, pp.1-5, 2002.

J. , M. L. Bots, and A. Hofman, Relation Between Blood Pressure and Stroke in Treated Hypertensives, Z. Vokó, Hypertension, vol.34, pp.1181-1185, 1999.

R. S. Telmisartan, K. K. Yusuf, J. Teo, and . Pogue, or Both in Patients at High Risk for Vascular Events. The ONTARGET Investigators, The ACCESS Study: Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors, pp.1547-1559, 2008.

J. Schrader, S. Lüders, and A. Kulschewski, The ACCESS Study: Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors, Stroke, vol.34, issue.7, pp.1699-1703, 2003.
DOI : 10.1161/01.STR.0000075777.18006.89

H. Arima, J. Chalmers, and M. Woodward, Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial, Journal of Hypertension, vol.24, issue.6, pp.1201-1208, 2004.
DOI : 10.1097/01.hjh.0000226212.34055.86

T. Post-stroke-antihypertensive, . Study, . Preliminary-result, . L. Pats-collaborative-group, L. Liu et al., 45. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators, The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized doubleblind intervention trial, pp.710-717, 1995.

H. Lithell, L. Hansson, and I. Skoog, The Study on COgnition and Prognosis in the Elderly (SCOPE) ? Major CV events and stroke in subgroups of patients, Eprosartan Compared With Nitrendipine for Secondary Prevention: Principal Results of a Prospective Randomized Controlled Study, pp.875-886, 2003.

J. Schrader, S. Lüders, and A. Kulschewski, Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events Hypotensive therapy in stroke survivors Effect of Antihypertensive Treatment on Stroke Recurrence. Hypertension-Stroke Cooperative Study Group, Atenolol in Secondary Prevention after Stroke. S. Eriksson, B-O. Olofsson, pp.1218-1224, 1970.

T. Dutch, T. Trial-study, A. Group, J. Algra, L. J. Van-gijn et al., Trial of secondary prevention with atenolol after transient ischaemic attack or non-disabling ischaemic stroke. The Dutch TIA Trial Study Group Effects of antihypertensive treatment in patients having already suffered from stroke Gathering the evidence; The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta- analysis, Stroke Stroke Blood Pressure and Stroke. An Overview of Published Reviews. C. M. M. Lawes, D. A. Bennett, V. L. Feigin et al. Stroke, vol.24, issue.56, pp.543-548, 1993.

S. E. Lakhan and M. T. Sapko, Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis, International Archives of Medicine, vol.2, issue.1, pp.30-57, 2009.
DOI : 10.1186/1755-7682-2-30

L. Liu, Y. Zhang, and G. Liu, The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients, Journal of Hypertension, vol.23, issue.12, pp.2157-2172, 2005.
DOI : 10.1097/01.hjh.0000194120.42722.ac

K. Irie, T. Yamaguchi, and K. Minematsu, The J-curve phenomenon in stroke recurrence, Stroke, vol.24, issue.12, pp.1844-1849, 1993.
DOI : 10.1161/01.STR.24.12.1844

A. Rodgers, S. Macmahon, and G. Gamble, Control of Hypertension and Risk of Stroke Recurrence International Society of Hypertension (ISH): statement on blood pressure lowering and stroke prevention International Society of Hypertension Writing Group Effects of Blood Pressure Lowering With Perindopril and Indapamide Therapy on Dementia and Cognitive Decline in Patients With Cerebrovascular Disease Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the Co-Sponsored by the Council on Cardiovascular Radiology and InterventionAmerican Stroke Association Council on Stroke: The American Academy of Neurology affirms the value of this guideline, Guidelines for the Management of Arterial Hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology, pp.147-60, 1996.

G. Mancia, G. De-backer, and A. Dominiczak, 2007 Guidelines for the Management of Arterial Hypertension, Journal of Hypertension, vol.25, issue.6, pp.1105-1187, 2007.
DOI : 10.1097/HJH.0b013e3281fc975a

A. M. Toschke, C. D. Wolfe, and P. U. Heuschmann, Antihypertensive Treatment after Stroke and All-Cause Mortality – An Analysis of the General Practitioner Research Database (GPRD), World Health Organization/International Society of Hypertension Guidelines for the Management of Hypertension, pp.105-111, 1999.
DOI : 10.1159/000223434

M. Alderman, K. Arakawa, and L. Beilin, Is the Relation of Systolic Blood Pressure to Risk of Cardiovascular Disease Continuous and Graded, or Are There Critical Values?, Journal of Hypertension Hypertension, vol.17, issue.42, pp.151-183, 1999.

R. Wennberg and C. Zimmermann, 72. The PROGRESS trial three years later: time for a balanced report of effectiveness The PROGRESS trial: questions about the effectiveness of angiotensin converting enzyme Commentary: The PROGRESS trial three years later: time for more action, Chez les adultes hypertendus sans complication ni diabète : quelle pression artérielle viser, pp.315-316, 2002.

J. M. Cruickshank, J. M. Thorp, and F. J. Zacharias, BENEFITS AND POTENTIAL HARM OF LOWERING HIGH BLOOD PRESSURE, The Lancet, vol.329, issue.8533, pp.581-584, 1987.
DOI : 10.1016/S0140-6736(87)90231-5

C. D. Farnett, W. D. Mulrow, and . Linn, Effectiveness of Lowering Blood Pressure to Prevent Stroke Versus to Prevent Coronary Events Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous?, Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial Study. P. Sleight, J. Redon, P. Verdecchia et al, pp.489-495, 1991.

J. S. Revisitedtnt-)-trial, F. H. Bangalore, C. Messerli, and . Wun, 85. The "J Curve Problem Revisited: Old and New Findings Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve A ESCAPE-ancillary blood pressure measurement study: end-digit preference in blood pressure measurement within a cluster-randomized trial Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure Multiple Clinic and Home Blood Pressure Measurements Versus Ambulatory Blood Pressure Monitoring A Blood pressure control by home monitoring: meta-analysis of randomised trials Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, the Treating to New Targets, pp.2897-2908, 1998.

. B. Study, P. S. Williams, S. M. Lacy, and . Thom, Les chiffres de l'hypertension. L'âge des artères. Les traitements de l'HTA. Rapport d'étude. Comité Français de lutte contre l'HTA (CFLHTA) http://www.comitehta.org/index.php?option=com_docman&Itemid=94&limitstart=5 94 Adherence lo long-term therapies. Evidence for action. WHO Library http://whqlibdoc.who.int/publications What should clinicians do when faced with conflicting recommendations? Find guidelines that are systematic and transparent, and make informed judgments Formindep. Association pour une formation et une information médicales indépendantes de tout autre intérêt que celui de la santé des personnes Blood-pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attacks M Protocol for Past BP: a randomised controlled trial of different blood pressure targets for people with a history of stroke of transient ischaemic attack (TIA) in primary care, Differential Impact of Blood Pressure?Lowering Drugs on Central Aortic Pressure and Clinical Outcomes Principal Results of the Conduit Artery Function Evaluation (CAFE), pp.1213-1225, 2003.